Sounds to me the product was not suitable , robust or flexible enough. Who got the gig with POC then ? Ted's basically saying back to the drawing board
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025